Navigation Links
ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
Date:3/6/2008

ped to treat different types of anemia, such as CIA. PBI-1402 has a distinct mechanism of action and does not act through EPO receptor. ProMetic has recently expanded its clinical program for PBI-1402 into the treatment of anemia in patients with myelodysplastic syndrome ("MDS"), a condition often referred to as "pre-leukemia".

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. (http://www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand (TM) enabling technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the U.K., U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the U.S., Europe, Asia and the Middle-East.

Forward Looking Statements

This press release contains forward-looking statements about ProMetic's objectives, strategies and businesses that involve risks and uncertainties. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, ProMetic's ability to develop, manufacture, and su
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
2. ProMetic provides business update - Over $35 million worth of business secured in January
3. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
4. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
5. VaxGen Reports Financial Update
6. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
7. Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis
8. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
9. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
10. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
11. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... September 22, 2014 Research ... addition of the "Global Biotechnology Reagents Market ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Biotechnology reagents are ... a system to detect and examine another substance ... used in laboratories to prepare, collect, and examine ...
(Date:9/22/2014)... have generated a new star-shaped molecule made up of interlocking ... created. , Known as a ,Star of David, ... a quarter of a century and the team,s findings are ... Consisting of two molecular triangles, entwined about each other three ... each triangle is 114 atoms in length around the ...
(Date:9/22/2014)... This is a professional and in-depth ... industry in Global and China. The report provides ... and industry chain structure. Global market analysis and Chinese ... history, developments, trends and competitive landscape of the market. ... also offered. , The report also focuses on development ...
(Date:9/22/2014)... California (PRWEB) September 22, 2014 ... primal desire to stay young has groomed and ... dollar industry worldwide. Growing emphasis on appearance maintenance ... Toxin is a neurotoxic protein obtained from the ... acetylcholine, resulting in muscle relaxation. With cosmetic indications ...
Breaking Biology Technology:Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 3Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3
... Mass., March 19 MacroChem,Corporation (OTC Bulletin Board: ... to the position of Chief Financial Officer, effective,immediately. ... and Vice,President, Corporate Development since joining the Company ... CFO of Bioenvision, Inc. prior to its,successful merger ...
... Years In 2008 And, Beyond, According To The Latest Research Released By ... ... the economy slides into,recession, IBISWorld today announced its list of industries with ... of the top 10 industries which IBISWorld predicts to do,well in 2008 ...
... of Standards and Technology (NIST) have set the stage ... today built from semiconductor compounds and future generations of ... upcoming paper in the Journal of the American Chemical ... of organic molecules can be assembled on the same ...
Cached Biology Technology:MacroChem Appoints David P. Luci as New CFO 2MacroChem Appoints David P. Luci as New CFO 3The Recession List - Top 10 Industries to Fly and Flop in 2008 2The Recession List - Top 10 Industries to Fly and Flop in 2008 3The Recession List - Top 10 Industries to Fly and Flop in 2008 4The Recession List - Top 10 Industries to Fly and Flop in 2008 5The Recession List - Top 10 Industries to Fly and Flop in 2008 6NIST team proves bridge from conventional to molecular electronics possible 2
(Date:9/23/2014)... -- Newest Market IPO,s and exchange ... significant investor attention with news concerning shareholder updates and new ... NXT-ID, Inc. (NASDAQ: NXTD ), Alibaba Group Holding ... MBLY ), GoPro, Inc. (NASDAQ: GPRO ) ... (NASDAQ: NXTD ) recently completed an essential round ...
(Date:9/22/2014)... ATLANTA September 23, 2014 A new American ... Supplemental Nutrition Assistance Program (SNAP), previously known as ... scores compared with income eligible non-participants. The authors ... programs aimed at enhancing the dietary quality of ... assist low-income individuals and households with the resources ...
(Date:9/22/2014)... genetic sequencing technologies continue to evolve rapidly, becoming part ... establish appropriate policies and regulatory frameworks to address potential ... policy issue of the Journal of Law, Medicine ... experts with the Center for Medical Ethics and Health ... the tools to jumpstart this process. , Experts ...
Breaking Biology News(10 mins):Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 2Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 3Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 4Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 5Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 6Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 7Federal food program puts food on the table, but dietary quality could be improved 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3
... The MRSA 'superbug' evades many of the measures introduced ... organism found almost everywhere in hospital wards, according to ... Scientists from the University of Bath have shown that ... called Acanthamoeba polyphaga, which is ubiquitous in the environment ...
... cancers actually share something in common ?a molecular "signature" made ... that target key cancer genes and promote malignant growth. ... emerging class of gene regulators and may also pave the ... The study appears online in the Proceedings of the National ...
... discovered that some type of protective system goes into ... is deficient. This discovery indicates a hidden safety net ... the immune system such as AIDS. The Mayo Clinic-led ... and is reported in the early online edition of ...
Cached Biology News:MRSA use amoeba to spread, new research shows 2Common molecular 'signature' identified in solid tumors 2Common molecular 'signature' identified in solid tumors 3Infant transplant patients resist infections that kill adult AIDS patients 2Infant transplant patients resist infections that kill adult AIDS patients 3
... is a new product number, created ... If showing no availability yet, please ... (Z71,487-9) or contact customer service for ... 100 mm, No. of sidearm 4 ...
... 15(S)-15-methyl PGF2α is a metabolically ... is a potent uterine stimulant ... administered intramuscularly to induce labor. ... serum progesterone concentrations when given ...
TGase3 (S-20)...
Amodiaquine...
Biology Products: